The global smart pills market was valued at USD 1.71 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2024 to 2030. Smart pills—also known as digital pills or ingestible sensors—represent a significant advancement in medical technology. These pills combine pharmaceutical treatments with digital monitoring capabilities. Embedded with tiny sensors, smart pills collect and transmit data regarding the body’s response to medication, such as vital signs or medication adherence, to external devices like smartphones or computers. By providing real-time insights into patient health and the effectiveness of treatments, smart pills enable healthcare professionals to tailor treatment plans with greater accuracy and intervene quickly when necessary.

Several key factors contribute to the growth of the smart pills market. These include favorable reimbursement conditions, a growing patient preference for less invasive treatments, advancements in endoscopic techniques, and the increasing incidence of conditions like colon cancer. Additionally, the benefits of smart pill technology—such as improvements in endoscopic procedures, targeted drug delivery, and simplified remote patient monitoring—are driving the market’s expansion.

The demand for non-invasive diagnostic methods is also increasing. The rise in chronic diseases, the aging population, and the growing use of digital health technologies have all contributed to the growing popularity of smart pills. These technologies offer patients ease, convenience, minimal discomfort, and reduced risks compared to more invasive procedures or treatments. As a result, both patients and healthcare providers are seeking more efficient and innovative treatment options, fueling the demand for smart pills. Moreover, the integration of artificial intelligence (AI) with smart pill technologies enhances data analytics capabilities, enabling quicker and more accurate diagnoses, improving treatment precision, and advancing preventive care approaches.

Gather more insights about the market drivers, restrains and growth of the Smart Pills Market

Regional Insights & Trends

The North America smart pills market led the global market in 2023, accounting for the largest revenue share of 37.5%. This dominance is primarily attributed to the rising prevalence of chronic diseases, especially gastrointestinal disorders and related cancers, in the region. North America is also known for its openness to adopting advanced medical technologies that aim to improve patient care. The presence of a large, discerning consumer base, along with regulatory approvals for cutting-edge devices, has further facilitated market expansion. The significant role played by the U.S. Food and Drug Administration (FDA) in approving innovative healthcare technologies, including those for remote health monitoring, has been crucial in fostering an environment conducive to market growth. Additionally, the presence of key industry players in North America supports ongoing product development and innovation.

U.S. Smart Pills Market Trends

The U.S. smart pills market dominated the North American market in 2023, contributing the largest share of revenue. The market’s growth is driven by a combination of factors, including the increasing prevalence of diseases, regulatory support, rapid technological advancements, and a robust healthcare system. The growing demand for pharmaceutical products, particularly those that enable more efficient and targeted treatments, has further established the U.S. as a major driver of smart pill technologies. As both a leader in healthcare innovation and a market with a high adoption rate of new medical technologies, the U.S. plays a pivotal role in advancing smart medical solutions and digital health tools.

Europe Smart Pills Market Trends

The European smart pills market is expected to witness significant growth during the forecast period, driven by a growing emphasis on minimally invasive diagnostic and treatment techniques. This trend positions smart pills as a viable alternative to traditional, more invasive diagnostic methods. Europe’s favorable reimbursement policies and the rapid development of advanced drug delivery systems further fuel the market’s expansion. Additionally, the rising public awareness around preventive healthcare and the strengthening of healthcare infrastructure in key countries such as Germany, the United Kingdom, and France contribute to market growth across the region.

The smart pills market in Germany led the European market in 2023, holding the largest revenue share. This dominance can be attributed to the country’s advanced healthcare infrastructure, which benefits from strong collaborations with prestigious universities, research institutions, and leading pharmaceutical companies. These institutions devote substantial resources to research and development (R&D), driving the continuous evolution and refinement of smart pill technologies. The focus on R&D in Germany plays a key role in the ongoing development of cutting-edge and efficient smart pill solutions, helping to sustain the country's leadership in the market.

Asia Pacific Smart Pills Market Trends

The smart pills market in the Asia Pacific region is projected to grow at a compound annual growth rate (CAGR) of 12.7% over the forecast period. This growth is largely driven by increasing demand for less invasive surgical procedures, such as capsule endoscopy. Capsule endoscopy, which offers the advantages of ease of administration and the ability to provide a detailed assessment of the gastrointestinal tract, is expected to replace traditional diagnostic methods. This shift to less invasive diagnostic tools contributes significantly to the region’s market expansion.

China led the smart pills market in Asia Pacific, holding the largest revenue share in 2023. This can be attributed to the high incidence of chronic disorders and the growing demand for smart pills that can deliver medication to specific locations within the digestive system or monitor vital signs, detect diseases, and provide real-time feedback. Additionally, China’s emphasis on digital healthcare, including the integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into the healthcare sector, is further enhancing the development and acceptance of smart pill technologies. These advancements in digital healthcare technologies are paving the way for innovations that improve diagnostic capabilities, treatment precision, and remote health monitoring, all of which contribute to the widespread adoption of smart pills in China.

Browse through Grand View Research's Category Pharmaceuticals Industry Research Reports.

  • The global heparin market size was estimated at USD 7.56 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2030. 
  • The global hormone replacement therapy market size was valued at USD 21.28 billion in 2022 and is expected to grow at a compounded annual growth rate (CAGR) of 6.6% from 2023 to 2030.

Key Companies & Market Share Insights

Some of the key companies in the smart pills market include Medtronic, Otsuka Holdings Co., Ltd., Olympus Corporation, CapsoCam Plus, Pentax Medical, JINSHAN Science & Technology (Group) Co., Ltd., Check-Cap Ltd. in the market are focusing on development & to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives.

  • Medtronic offers an innovative PillCam technology. This ingestible capsule enables non-invasive imaging of the gastrointestinal tract, particularly the colon, aiding in the diagnosis of disorders such as colorectal cancer.
  • Olympus focuses on developing advanced imaging technologies, including its capsule endoscopes. These smart pills are designed to provide high-quality visual data from the gastrointestinal tract, facilitating the early detection of diseases.

Key Smart Pills Companies:

The following are the leading companies in the smart pills market. These companies collectively hold the largest market share and dictate industry trends.

  • Medtronic 
  • Otsuka Holdings Co., Ltd.
  • Olympus Corporation
  • CapsoCam Plus
  • Pentax Medical
  • JINSHAN Science & Technology (Group) Co., Ltd. 
  • Check-Cap Ltd. 
  • etectRx
  • INTROMEDIC 
  • Shenzen Jifu Medical Technology Co., Ltd
  • BodyCapUSA

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.